Enhanced Games Debut Highlights $1.2 B Valuation and Direct‑to‑Consumer Health Pitch

The event took place in a temporary arena built in the parking lot of Resorts World Las Vegas, a casino complex known for high‑stakes entertainment. Organisers marketed the competition as a test of human limits, allowing participants to use FDA‑approved performance‑enhancing substances under medical supervision.

Forty‑two competitors tackled eight disciplines: deadlift, 100‑meter sprint, clean & jerk, snatch, and four swimming races (50 m and 100 m butterfly, 50 m and 100 m freestyle). Notable sign‑ups included former world champion sprinter Fred Kerley and retired Australian swimmer James Magnussen. Strongman Thor Bjornsson attempted to lift 510 kg, a feat that would earn him a $250,000 bonus.

Cam McEvoy, an Australian swimmer, warned that any records set will be recognized only within the Enhanced Games community. He likened the drug‑plus‑polyurethane swimsuit combo to “throwing on a set of fins,” suggesting the results will lack legitimacy outside the event.

Enhanced Group, the corporate entity behind the Games, opened trading above $8 per share and closed at $10.17, a 21% rise that briefly placed the company at a $1.2 billion market value. The surge reflects investor interest in the company’s broader plan to sell anti‑aging and muscle‑building products directly to consumers, rather than relying on the novelty of a one‑off sporting spectacle.

The public debut reveals a two‑pronged strategy: a headline‑grabbing competition to generate buzz, and a health‑tech platform aimed at “looksmaxxers” and tech‑savvy buyers. By framing the Games as a proof‑of‑concept for drug‑assisted performance, the company hopes to translate spectacle into sales of peptides, growth hormone, and related supplements.

What to watch next: the market’s reaction to post‑event product launches and any regulatory scrutiny of the company’s direct‑to‑consumer health claims.